Last reviewed · How we verify

NCT06170437

Smoke-free Home Study in Subsidized Housing

Recruiting now NA Last updated 24 February 2025
What this trial tests

NA trial testing Smoke-free home resident intervention in Tobacco Dependence in 544 participants. Currently enrolling.

Timeline
12 July 2024
Primary endpoint
31 December 2026
31 August 2027

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment544
Start date12 July 2024
Primary completion31 December 2026
Estimated completion31 August 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Tobacco Dependence or Tobacco Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comprehensive smoke-free policies have the potential to substantially reduce tobacco-related disparities among populations in subsidized housing. This study fills this gap by identifying approaches to increase the implementation of smoke-free policies in all types of subsidized housing by increasing the voluntary adoption of smoke-free homes and promoting access to smoking cessation services.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Healthy Homes Study: Protocol for a cluster randomized trial of a place-based smoke-free home intervention in affordable housing.
    Hawes MR, Chakravarty D, Cheng J, Handley MA, et al · · 2025 · PMID 40729126 · DOI 10.1371/journal.pone.0328786

Verify or expand the search:

Other recruiting trials for Tobacco Dependence

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06170437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing